2021-12-012021-12-012001-03Usta, M. vd. (2001). "Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions". Clinical Nephrology, 55(3), 260-262.0301-0430http://hdl.handle.net/11452/22919eninfo:eu-repo/semantics/closedAccessConvertingEnzymeInhibitorUrology & nephrologyHumansAntihypertensive agentsFemaleGlomerulonephritisKidney glomerulusLosartanMaleProteinuriaReceptors, angiotensinLetter0001721840000142-s2.0-003510508126026255311316250Urology & nephrologyRenin Angiotensin Aldosterone System; Angiotensin Receptor Antagonists; Diabetic NephropathiesReninAngiotensinAngiotensin 2 receptor antagonistDipeptidyl carboxypeptidase inhibitorEnalaprilLosartanDrug effectAdultAlport syndromeClinical articleControlled studyDiabetic nephropathyGlomerulonephritisDrug selectivityDrug specificityEssential hypertensionFemaleFocal glomerulosclerosisGlomerulopathyGlomerulosclerosisMembranous glomerulonephritisGlomerulus filtrationGlomerulus filtration rateImmunoglobulin A nephropathyHumanHistopathologyImmunosuppressive treatmentKidney biopsyKidney diseaseKidney functionKidney plasma flowLetterMaleMembranoproliferative glomerulonephritisProtectionProteinuriaRenin angiotensin aldosterone systemRisk factor